No definition available.
Sequelae of infectious and parasitic diseases
EFO MESH Endpoint Browser PheWeb
AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1281 |
4. Check minimum number of eventsNone |
1281 |
5. Include endpoints |
3605 |
6. Filter based on genotype QC (FinnGen only) |
3230 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Sequelae of infectious and parasitic diseases
based on the number of shared cases.
Similar with more cases:
- Sequelae of infectious and parasitic diseases, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 38037 | 16544 | 20739 |
| Only index persons | 26574 | 12375 | 14199 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.54 | 0.47 | 0.58 |
| Only index persons | 0.50 | 0.45 | 0.54 |
| Median age at first event (years) | |||
| Whole population | 38.55 | 41.13 | 35.62 |
| Only index persons | 23.03 | 26.29 | 20.18 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3230 | 1560 | 1670 |
| Unadjusted period prevalence (%) | 0.66 | 0.55 | 0.77 |
| Median age at first event (years) | 24.07 | 20.02 | 27.85 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3325
- Matched controls
- 33250
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
07999
ICD-8 Finland
Other viral diseases, Viral infection, unspecified
+∞
307.7
786
*
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
+∞
307.7
529
*
07997
ICD-8 Finland
Other viral diseases, Viroses suspectae
+∞
307.7
787
*
B91
ICD-10 Finland
Sequelae of poliomyelitis
906.9
260.0
252
*
07988
ICD-8 Finland
Other viral diseases
+∞
241.7
229
*
07900
ICD-8 Finland
Other viral diseases, Molluscum contagiosum
+∞
151.2
144
*
07910
ICD-8 Finland
Other viral diseases, Viral warts
+∞
118.4
113
*
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
8.8
96.5
123
145
Y3409
ICD-8 Finland
Follow-up examination of illness, accident or surgery, Treated inactive pulmonary tuberculosis
36.2
91.1
57
16
1380A
ICD-9 Finland
Late effects of acute poliomyelitis[SEQUELAE POLIOMYELITIDIS]
+∞
76.3
73
*
1370A
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,TUBERKULOOSIARPI]
+∞
74.2
71
*
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
4.6
74.2
181
409
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
19.4
56.3
44
23
04499
ICD-8 Finland
Late effects of actue poliomyelitis
+∞
55.4
53
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
55.2
743
4175
N70
ICPC
Poliomyelitis
193.2
55.1
57
*
1370X
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,MUU JÄLKITILA]
+∞
53.3
51
*
01908
ICD-8 Finland
Late effects of tuberculosis, Sequelae aliae o tuberculosis organorum respirationis
+∞
52.2
50
*
B90.0
ICD-10 Finland
Sequelae of central nervous system tuberculosis
+∞
51.2
49
*
07981
ICD-8 Finland
Other viral diseases, Infectio virosa adeno alia
+∞
49.1
47
*
J96.1
ICD-10 Finland
Chronic respiratory failure
4.2
46.3
124
301
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
453.8
45.4
45
*
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
3.3
42.7
164
510
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.4
41.4
295
1276
R03AC02
ATC
salbutamol; inhalant
1.6
38.8
1763
13696
01102
ICD-8 Finland
Pulmonary tuberculosis, Non cavernosa
11.9
38.6
39
33
R03AC12
ATC
salmeterol; inhalant
2.8
38.0
202
757
R03BB01
ATC
ipratropium bromide; inhalant
2.8
37.6
200
750
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
36.8
508
2842
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
36.6
397
2040
B90.2
ICD-10 Finland
Sequelae of tuberculosis of bones and joints
+∞
35.5
34
*
49300
ICD-8 Finland
Asthma, bronchiale
3.5
35.4
125
369
R03DA04
ATC
theophylline; systemic, rectal
2.4
33.3
241
1048
J47
ICD-10 Finland
Bronchiectasis
4.1
31.8
88
219
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
29.3
618
3909
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
3.6
29.2
98
280
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.3
27.4
226
1039
78880
ICD-8 Finland
Other general symptoms, Pyrexia of unknown origin
6.8
27.2
42
62
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
2.3
27.0
211
948
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
26.2
347
1903
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
4.1
26.1
72
179
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.9
25.9
340
1858
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.0
25.1
114
392
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
24.7
894
6414
R03BB04
ATC
tiotropium bromide; inhalant
1.9
24.6
345
1927
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
27.8
24.4
33
12
R03BA01
ATC
beclometasone; inhalant
1.7
24.0
453
2766
48609
ICD-8 Finland
Pneumonia, unspecified
3.6
23.5
79
226
H02AB06
ATC
prednisolone; systemic
1.4
22.8
1465
11742
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
22.3
228
1140
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
4.2
21.7
57
137
J01AA02
ATC
doxycycline; systemic
1.5
20.0
2440
21723
J01FA06
ATC
roxithromycin; oral
1.4
19.5
1207
9530
H02AB04
ATC
methylprednisolone; systemic
1.6
19.4
442
2829
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
3.0
18.5
80
268
48509
ICD-8 Finland
Bronchopneumonia, unspecified
3.5
18.2
63
184
49099
ICD-8 Finland
Bronchitis, unspecified
3.6
17.4
56
156
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
17.0
597
4211
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
3.5
17.0
59
173
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
5.1
16.9
35
69
R04.2
ICD-10 Finland
Haemoptysis
2.4
16.9
118
506
01904
ICD-8 Finland
Late effects of tuberculosis, Adhaesiones pleurae
+∞
16.7
16
*
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.7
16.0
310
1899
R06.0
ICD-10 Finland
Dyspnoea
1.4
15.8
793
5987
01909
ICD-8 Finland
Late effects of tuberculosis, Sequelae NUD o tuberculosis organorum respirationis
+∞
15.6
15
*
R03BA05
ATC
fluticasone; inhalant
1.5
15.6
522
3640
R03BA02
ATC
budesonide; inhalant
1.5
15.3
518
3620
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
3.5
14.8
50
144
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.0
14.8
163
839
J45.8
ICD-10 Finland
Mixed asthma
2.4
14.5
100
427
59010
ICD-8 Finland
Infections of kidney, Pyelonephritis
3.1
14.3
60
198
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.0
14.1
160
831
C03CA01
ATC
furosemide; systemic
1.4
14.1
935
7378
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.4
13.6
93
395
J01DA01
ATC
[U] cefalexin
1.3
13.6
1869
16384
79199
ICD-8 Finland
Headache
3.2
13.6
53
168
B90.1
ICD-10 Finland
Sequelae of genitourinary tuberculosis
+∞
13.5
13
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.2
13.4
113
525
78310
ICD-8 Finland
Symptoms referable to respiratory system, Haemoptysis
6.3
13.3
22
35
J01MA12
ATC
levofloxacin; systemic
1.5
13.2
537
3883
R03BB02
ATC
oxitropium bromide; inhalant
3.8
13.1
39
103
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.9
13.0
156
826
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
12.9
611
4546
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
4.2
12.7
33
79
N02AX02
ATC
tramadol; systemic, rectal
1.3
12.6
1257
10496
0110A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung, infiltrative[TUBERCULOSIS PULMONUM INFILTRATIVA, BAKTER.VARMA]
32.1
12.6
16
5
07980
ICD-8 Finland
Other viral diseases, Infectio virosa ECHO
+∞
12.5
12
*
B90.8
ICD-10 Finland
Sequelae of tuberculosis of other organs
+∞
12.5
12
*
N03AX16
ATC
[U] pregabalin
1.4
12.1
631
4766
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
11.1
12.0
22
20
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
12.0
1029
8402
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
11.9
240
1486
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
2.3
11.5
89
400
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.9
11.5
151
825
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
5.7
11.5
21
37
01930
ICD-8 Finland
Late effects of tuberculosis, Columnae vertebralis
+∞
11.5
11
*
07940
ICD-8 Finland
Other viral diseases, Foot and mouth disease
+∞
11.5
11
*
01901
ICD-8 Finland
Late effects of tuberculosis, Emphysema
+∞
11.5
11
*
M89.6
ICD-10 Finland
Osteopathy after poliomyelitis
+∞
11.5
11
*
TGC00
NOMESCO Finland
Bronchial lavation
2.4
11.4
78
332
B94.80
ICD-10 Finland
Late effects of bacterial meningitis
120.4
11.4
12
*
A10AA01, ,
ATC
2.2
11.3
90
409
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
11.3
892
7181
M05BA04
ATC
alendronic acid; oral
1.7
11.3
234
1458
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.4
11.0
76
325
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
3.8
11.0
33
88
7863A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Haemoptysis
5.4
10.9
21
39
R03DC03
ATC
montelukast; oral
1.4
10.8
443
3203
R96
ICPC
Asthma
1.6
10.7
253
1627
J01FF01
ATC
clindamycin; systemic
1.3
10.7
745
5880
A86
ICD-10 Finland
Unspecified viral encephalitis
4.9
10.7
23
47
J01MA14
ATC
moxifloxacin; systemic
1.6
10.6
257
1663
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.3
10.6
82
369
L28
ICPC
Limited function/disability (L)
1.4
10.6
523
3908
H3603, E103,
ICD-10 Finland
3.5
10.6
36
105
1373X
ICD-9 Finland
Late effects of tuberculosis of bones and joints
+∞
10.4
10
*
1370D
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,PLEURAFIBROOSI]
+∞
10.4
10
*
79388
ICD-8 Finland
Observation, without need for further medical care, Morbi alii definiti
4.1
10.4
28
69
R03AC03
ATC
terbutaline; inhalant
1.5
10.3
375
2648
H3600, E103,
ICD-10 Finland
3.1
10.3
41
132
03400
ICD-8 Finland
Streptococcal sore throat and scarlet fever, Streptococcal sore throat
4.2
10.1
26
62
A16.2
ICD-10 Finland
Tuberculosis of lung, without mention of bacteriological or histological confirmation
40.2
10.0
12
*
A10AB01
ATC
insulin (human); parenteral
2.0
9.9
110
569
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
9.9
1307
11218
R03AC13
ATC
formoterol; inhalant
1.8
9.8
143
808
78080
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Meningismus
55.2
9.6
11
*
34599
ICD-8 Finland
Epilepsy, Other and unspecified
4.8
9.5
21
44
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
15.1
9.5
15
10
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
9.5
509
3852
J01DA09
ATC
[U] cefadroxil
1.3
9.4
722
5769
01210
ICD-8 Finland
Other respiratory tuberculosis, Tuberculosis pleurae, pleuritis exsudativa tuberculosa
30.1
9.4
12
*
01903
ICD-8 Finland
Late effects of tuberculosis, Fibrosis pulmonum
+∞
9.4
9
*
07959
ICD-8 Finland
Other viral diseases, Virosis cytomegalica NUD
+∞
9.4
9
*
B94.8
ICD-10 Finland
Sequelae of other specified infectious and parasitic diseases
+∞
9.4
9
*
H02AB07
ATC
prednisone; oral
1.4
9.4
386
2791
204
Kela drug reimbursment
Leukemia lymphatica
2.0
9.4
93
463
127
Kela drug reimbursment
Transplant complication
2.7
9.3
47
173
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
9.2
219
1411
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
9.2
445
3308
J01DA06
ATC
[U] cefuroxime
1.4
9.2
377
2723
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
4.2
9.2
24
58
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
9.1
697
5563
R02
ICPC
Shortness of breath/dyspnoea
1.4
9.0
348
2487
R50.9
ICD-10 Finland
Fever, unspecified
1.4
8.9
415
3065
42700
ICD-8 Finland
Symptomatic heart disease, Congestive heart failure
4.2
8.9
23
55
SPAT1229
SPAT
Assessment of need for aid
1.6
8.7
197
1255
A15.3
ICD-10 Finland
Tuberculosis of lung, confirmed by unspecified means
50.1
8.7
10
*
0310A
ICD-9 Finland
Diseases due to other mycobacteria, Pulmonary
50.1
8.7
10
*
N05BA04
ATC
oxazepam; oral
1.3
8.6
728
5883
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
8.6
513
3942
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
8.6
1442
12659
34609
ICD-8 Finland
Migraine, Unspecified
3.7
8.4
26
71
N06AB04
ATC
citalopram; systemic
1.3
8.4
575
4511
B94.9
ICD-10 Finland
Sequelae of unspecified infectious or parasitic disease
90.3
8.4
9
*
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
3.9
8.4
24
62
L04AX01
ATC
azathioprine; systemic
1.8
8.4
112
617
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
8.4
779
6373
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
3.1
8.4
34
111
01900
ICD-8 Finland
Late effects of tuberculosis, Bronchiectasia
+∞
8.3
8
*
01510
ICD-8 Finland
Tuberculosis of bones and joints, Of hip
+∞
8.3
8
*
1398X
ICD-9 Finland
Late effects of other infectious and parasitic diseases, Late effects of other and unspecified infectious and parasitic diseases
+∞
8.3
8
*
01931
ICD-8 Finland
Late effects of tuberculosis, Coxae
+∞
8.3
8
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.2
8.3
66
302
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
8.3
387
2860
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
8.2
275
1912
N03AG01
ATC
valproic acid; systemic, rectal
1.6
8.2
165
1023
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
8.1
87
446
01106
ICD-8 Finland
Pulmonary tuberculosis, Pulmonum alia sive NUD
33.4
8.1
10
*
78410
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Emesis
6.3
8.0
20
32
N05CF01
ATC
zopiclone; oral
1.3
8.0
918
7706
01107
ICD-8 Finland
Pulmonary tuberculosis, Suspecta
7.2
7.9
18
25
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.4
7.9
351
2570
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.7
7.9
129
756
A02BA02
ATC
ranitidine; systemic
1.3
7.9
520
4059
N03AX12
ATC
[U] gabapentin; oral
1.4
7.8
420
3179
Z94.0
ICD-10 Finland
Kidney transplant status
2.9
7.7
35
122
C03DA01
ATC
spironolactone; oral
1.4
7.7
326
2367
N05BA01
ATC
diazepam; systemic, rectal
1.4
7.7
348
2556
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
7.6
598
4777
J01MA02
ATC
ciprofloxacin; systemic
1.2
7.6
1087
9342
1240
FHL
Bronchoscopy
2.6
7.5
42
164
J01FA10
ATC
azithromycin; systemic
1.2
7.5
1531
13656
J45
ICD-10 Finland
Asthma
1.5
7.4
267
1881
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
2.9
7.4
33
114
59000
ICD-8 Finland
Infections of kidney, Pyelonephritis chronica
4.4
7.4
18
41
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
6.5
7.4
18
28
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
4.0
7.3
20
50
B94.89
ICD-10 Finland
Sequelae of other specified infectious and parasitic diseases
+∞
7.3
7
*
06608
ICD-8 Finland
Late effects of viral encephalitis, Alii casus postencephalitici
+∞
7.3
7
*
1370C
ICD-9 Finland
Late effects of tuberculosis, Late effects of respiratory or unspecified tuberculosis[HENGITYSELINTUBERKUL JÄLKITILA,BRONKIEKTASIAT]
+∞
7.3
7
*
L01BB01, ,
ATC
10.9
7.3
13
12
J02AC01
ATC
fluconazole; systemic
1.2
7.3
992
8473
85000
ICD-8 Finland
Concussion, Current or unspecified
2.1
7.2
68
333
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
1.9
7.2
87
465
N05AH04
ATC
quetiapine; oral
1.3
7.2
479
3739
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
7.2
578
4632
L04AA01
ATC
[U] ciclosporin
2.7
7.1
37
139
XG410
NOMESCO Finland
Flow-volume spirometry
1.8
7.1
98
546
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
3.2
7.1
27
85
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
2.2
7.1
54
243
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
7.1
241
1680
N03AX18
ATC
lacosamide; systemic
3.3
7.1
26
80
A10AA02, ,
ATC
1.8
7.1
108
621
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
7.1
185
1222
01101
ICD-8 Finland
Pulmonary tuberculosis, Cavernosa
8.8
7.0
14
16
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.2
7.0
58
270
S72.4
ICD-10 Finland
Fracture of lower end of femur
3.0
7.0
29
96
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.2
7.0
53
238
R95
ICPC
Chron obstructive pulmonary disease
1.9
7.0
78
406
Y0899
ICD-8 Finland
Investigation of musculoskeletal system
3.9
7.0
20
52
J01CA04
ATC
amoxicillin; systemic
1.2
6.9
2365
22137
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.6
6.9
151
957
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
4.0
6.9
19
48
68409
ICD-8 Finland
Impetigo, Unspecified
13.8
6.9
11
8
N05CD07
ATC
temazepam; oral
1.4
6.8
331
2460
R03AK08
ATC
formoterol and beclometasone; inhalant
1.7
6.8
112
659
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
10.9
6.8
12
11
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
6.8
107
622
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.0
6.8
74
383
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
6.7
353
2657
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.8
6.7
91
505
A15.2
ICD-10 Finland
Tuberculosis of lung, confirmed histologically
16.7
6.7
10
6
N05CD02
ATC
nitrazepam; oral
2.2
6.7
52
236
R53
ICD-10 Finland
Malaise and fatigue
1.3
6.7
706
5847
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.5
6.6
173
1142
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
6.6
287
2093
J01DA08
ATC
[U] cefaclor
1.5
6.6
210
1445
S97
ICPC
Chronic ulcer skin
1.6
6.6
161
1047
GD1AD
NOMESCO Finland
Thorax CT examination
1.6
6.6
152
977
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
6.6
421
3269
R05FB02
ATC
cough suppressants and expectorants; systemic
1.2
6.5
998
8608
R05CB01
ATC
acetylcysteine; inhalant, oral
2.3
6.5
47
207
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.0
6.5
65
327
A01AB10
ATC
natamycin; local oral
1.9
6.5
76
404
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
6.4
268
1942
A15.9
ICD-10 Finland
Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically
70.0
6.4
7
*
01500
ICD-8 Finland
Tuberculosis of bones and joints, Of vertebral column
70.0
6.4
7
*
A02BC05
ATC
esomeprazole; systemic
1.2
6.4
1084
9444
N06AX16
ATC
venlafaxine; oral
1.4
6.4
356
2708
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
6.3
242
1726
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.8
6.3
95
545
N06AX11
ATC
mirtazapine; oral
1.2
6.3
927
7960
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.4
6.3
243
1737
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
18.0
6.3
9
5
P01AB01
ATC
metronidazole; oral, rectal
1.2
6.3
1039
9032
R5140
NOMESCO Finland
Monitoring the use of the aid
1.4
6.3
289
2132
1374X
ICD-9 Finland
Late effects of tuberculosis of other specified organs
+∞
6.3
6
*
07951
ICD-8 Finland
Other viral diseases, Virosis cytomegalica asquisita
+∞
6.3
6
*
07998, ,
ICD-8 Finland
+∞
6.3
6
*
Y3429
ICD-8 Finland
Follow-up examination of illness, accident or surgery, Other inactive tuberculosis cases
26.7
6.2
8
*
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
2.6
6.2
33
126
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
6.2
999
8655
01220
ICD-8 Finland
Other respiratory tuberculosis, Pleurisy with effusion without mention of cause
7.0
6.2
14
20
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.9
6.2
28
98
A06AD11
ATC
lactulose; oral
1.3
6.2
408
3179
E0000UV, ,
ATC
1.2
6.2
1090
9530
SPAT1262
SPAT
Handing over of treatment supplies
1.3
6.2
417
3261
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
6.2
497
3980
A02BC03
ATC
lansoprazole; oral
1.2
6.2
755
6357
71490
ICD-8 Finland
Other specified forms of arthritis, Arthritis postinfectiosa NUD
6.3
6.2
15
24
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
5.7
6.1
16
28
N06AA09
ATC
amitriptyline; systemic
1.4
6.1
231
1645
J01DB01
ATC
cefalexin; oral
1.2
6.1
2425
22868
L04AD02
ATC
tacrolimus; systemic
2.7
6.1
31
116
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
6.1
739
6217
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
2.9
6.0
27
94
Y0599
ICD-8 Finland
Investigation of digestive system
2.2
6.0
46
208
L04AA06
ATC
mycophenolic acid; systemic
2.2
6.0
50
234
N02AC04
ATC
dextropropoxyphene; oral
1.7
6.0
104
621
TK800
NOMESCO Finland
Hemodialysis
2.1
6.0
56
274
AA1AD
NOMESCO Finland
CT of head and brain
1.2
6.0
752
6342
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
198
895
2.29
24.99
3.8
2.8
—
—
—
0
0
666
4735
1.51
18.43
3.1
2.5
13.38
13.08
umol/l
0.46
625
4411
574
4052
1.50
16.24
3.2
2.6
22.95
22.80
%
0.09
542
3763
612
4394
1.48
15.90
3.1
2.5
2.32
2.31
g/l
0.11
568
4065
1526
12845
1.35
15.47
7.5
6.5
57.86
57.70
%
0.20
1475
12289
642
4678
1.46
15.42
2.1
1.9
—
—
—
0
0
1544
13071
1.34
14.83
7.7
6.6
27.17
27.38
%
0.33
1495
12419
75
281
2.71
14.23
5.6
3.8
—
—
—
0
0
1671
14392
1.32
13.88
7.8
6.6
0.19
0.19
e9/l
0.20
1488
12623
1622
13920
1.32
13.78
7.4
6.4
0.59
0.59
e9/l
0.76
1434
12014
1624
13949
1.32
13.67
7.4
6.4
0.04
0.04
e9/l
0.05
1437
12038
488
3477
1.47
12.97
2.0
1.8
—
—
—
0
0
1559
13457
1.30
12.06
9.1
7.0
1.21
1.21
mmol/l
0.07
1349
11633
1636
14219
1.30
11.98
7.6
6.5
1.84
1.90
e9/l
1.25
1469
12597
110
546
2.05
11.08
1.8
1.5
—
—
—
0
0
447
3230
1.44
10.94
8.2
7.8
5.26
5.09
kpa
2.62
433
3101
447
3230
1.44
10.94
8.2
7.8
11.77
12.25
kpa
1.13
435
3101
443
3209
1.44
10.69
8.2
7.7
1.62
0.94
mmol/l
2.71
382
2606
454
3305
1.43
10.67
2.0
1.8
—
—
—
0
0
273
1792
1.57
10.62
3.9
3.4
5.39
5.16
kpa
3.22
263
1709
1406
12181
1.27
9.84
2.8
2.4
78.11
76.75
nmol/l
1.01
1289
11088
233
1511
1.58
9.56
3.7
3.3
2.07
1.73
mmol/l
0.57
174
1117
1382
11996
1.26
9.37
8.5
6.4
1.21
1.21
mmol/l
0.28
1286
11112
394
2873
1.42
9.12
8.7
8.1
94.90
95.55
%
0.92
388
2778
586
4561
1.35
9.11
4.0
3.3
0.81
0.82
mmol/l
1.88
548
4316
1726
15463
1.24
8.53
10.6
9.6
4.27
4.15
e9/l
1.19
1521
13471
363
2646
1.42
8.41
2.2
2.2
0.21
0.21
g/l
0.18
337
2471
1424
12515
1.24
8.32
15.2
15.5
1.24
1.27
inr
1.50
1216
10451
105
569
1.87
8.30
6.1
6.3
196.29
524.56
iu/ml
1.20
17
77
366
2695
1.40
8.00
2.3
2.2
367.80
376.79
nmol/l
0.33
344
2489
39
143
2.75
7.86
1.2
1.1
—
—
—
0
0
1212
10534
1.24
7.66
4.4
3.8
48.11
65.71
ng/l
0.76
843
7179
103
571
1.83
7.61
5.1
4.3
2.63
2.57
mmol/l
0.09
70
371
240
1653
1.49
7.51
10.3
9.9
24.89
24.32
mmol/l
1.83
230
1613
67
323
2.10
7.41
1.1
1.1
—
—
—
0
0
905
7683
1.24
6.96
4.6
4.0
0.00
0.00
estimate
1.74
348
2655
335
2489
1.38
6.94
9.7
7.2
10.08
9.97
mmol/l
0.11
309
2390
33
120
2.77
6.79
1.9
1.7
—
—
—
0
0
153
977
1.59
6.78
2.5
2.3
583.18
437.42
ug/l
0.36
148
917
461
3614
1.32
6.71
7.8
5.9
1.05
1.03
mmol/l
0.85
420
3364
1368
12165
1.21
6.63
5.8
5.0
35.12
35.72
g/l
3.61
1265
11431
1576
14215
1.21
6.56
6.9
6.4
11.23
11.75
umol/l
0.81
1497
13569
275
1996
1.41
6.53
1.9
1.7
—
—
—
0
0
1003
8663
1.23
6.48
3.3
2.6
59.77
68.87
u/l
0.45
930
8063
335
2537
1.36
6.16
9.3
7.6
1.29
1.36
mmol/l
0.46
325
2488
2121
19733
1.21
6.16
5.3
4.3
13.11
11.83
mm/h
3.30
2019
18553
33
128
2.59
6.04
5.6
3.5
—
—
—
0
0
851
7276
1.23
5.99
2.7
2.3
2.90
2.83
mg/l
0.42
751
6278
288
2141
1.38
5.95
3.0
2.9
10.71
10.65
g/l
0.08
269
1979
733
6179
1.24
5.88
3.4
2.7
4.97
5.47
e6/l
0.53
682
5630
875
7515
1.22
5.88
1.9
1.7
19.56
19.99
nmol/l
0.37
778
6451
1056
9259
1.21
5.71
3.6
3.4
2.34
2.35
mmol/l
0.99
955
8472
139
914
1.54
5.48
1.5
1.5
92.51
8.15
iu/ml
0.55
28
152
100
608
1.66
5.45
1.4
1.5
—
—
—
0
0
232
1700
1.39
5.26
1.7
1.7
—
—
—
0
0
120
771
1.58
5.25
1.7
1.7
—
—
—
0
0
53
269
1.99
5.21
2.0
1.6
—
—
—
0
0
13
22
5.93
5.21
1.3
1.1
—
—
—
0
0
232
1708
1.39
5.12
6.8
6.6
25.28
24.37
mmol/l
2.90
227
1637
166
1153
1.46
5.06
1.9
1.5
8.40
16.93
iu/ml
—
6
36
503
4130
1.26
5.06
2.4
2.1
30.24
29.64
s
0.74
494
4011
2188
20582
1.18
4.98
9.5
8.0
79.56
78.62
u/l
0.40
2104
19586
1424
12933
1.18
4.98
3.6
3.1
129.65
127.46
ug/l
0.14
1356
12133
917
8023
1.20
4.95
3.6
3.2
1422.23
1515.85
ng/l
0.28
793
6839
57
304
1.89
4.88
5.4
6.1
7.15
7.60
mmol/l
0.31
50
258
1715
15832
1.17
4.85
6.5
5.0
6.91
6.74
mmol/l
1.58
1651
15074
306
2371
1.32
4.84
2.8
2.6
73.08
69.92
e9/l
0.59
230
1748
958
8429
1.19
4.84
2.6
2.2
277.37
228.10
u/l
0.50
903
8001
264
2003
1.35
4.83
1.5
1.4
—
—
—
0
0
95
590
1.63
4.81
1.4
1.3
—
—
—
0
0
95
590
1.63
4.81
1.4
1.3
—
—
—
0
0
246
1848
1.36
4.80
1.4
1.3
440.86
214.55
u/ml
0.92
236
1719
265
2016
1.34
4.76
4.6
3.9
103.83
90.66
ng/l
0.81
215
1753
86
523
1.66
4.74
1.4
1.5
—
—
—
0
0
76
447
1.72
4.73
3.4
2.7
240.50
865.91
u/ml
—
6
33
14
30
4.68
4.67
1.3
1.1
—
—
—
0
0
1311
11876
1.17
4.63
2.2
2.1
98.43
95.95
pmol/l
0.78
740
6490
347
2755
1.29
4.59
3.9
3.5
—
—
—
0
0
139
953
1.48
4.56
4.0
3.6
24.55
24.82
mmol/l
0.53
129
870
1315
11927
1.17
4.55
14.3
11.4
0.00
0.00
e9/l
0.26
1084
9714
168
1198
1.42
4.49
1.6
2.1
41.46
39.61
u/l
0.55
153
1079
14
32
4.39
4.43
1.4
1.2
—
—
—
0
0
1544
14200
1.16
4.43
4.4
3.9
2.81
0.12
estimate
0.47
358
2773
720
6221
1.20
4.39
2.0
1.7
1.06
1.12
mg/l
0.24
566
4779
1521
13978
1.16
4.39
4.4
3.8
0.00
0.00
estimate
1.08
365
2898
1844
17204
1.16
4.33
5.4
4.7
1021.52
1675.99
e6/l
0.26
27
258
99
640
1.56
4.29
2.9
2.1
129.53
129.82
g/l
0.04
86
495
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
139
2.24
4.24
1.2
1.1
—
—
—
0
0
1815
16960
1.15
4.05
3.2
3.1
—
—
—
0
0
700
6092
1.19
3.91
1.4
1.3
1.71
1.60
u/ml
0.08
188
1703
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
128
895
1.45
3.85
4.4
2.7
0.35
0.35
iu/ml
0.05
78
486
1529
14147
1.15
3.84
4.5
3.9
7.21
4.85
estimate
0.18
384
2971
223
1715
1.32
3.77
1.4
1.3
39.37
54.16
au/ml
0.72
14
126
25
108
2.32
3.75
1.2
1.1
71.80
212.34
ng/l
—
10
26
1040
9373
1.16
3.74
3.4
3.3
30.65
36.68
u/l
2.09
976
8858
103
697
1.49
3.67
1.6
1.7
—
—
—
0
0
118
825
1.45
3.58
1.5
1.7
0.23
0.24
g/l
0.72
113
786
343
2806
1.25
3.57
5.3
3.5
5.90
5.83
kpa
0.73
335
2728
148
1078
1.39
3.57
1.3
1.3
0.73
0.90
u/ml
0.16
12
90
412
3441
1.23
3.54
2.5
2.6
128.15
131.31
ug/g
0.08
318
2796
2139
22411
0.87
3.45
25.4
20.1
332.13
332.56
g/l
1.27
2128
22255
92
617
1.51
3.44
1.4
1.2
3.57
3.77
mmol/l
1.09
87
578
47
267
1.77
3.40
1.1
1.0
—
—
—
0
0
652
5706
1.18
3.38
1.9
1.7
15300994.05
34040329.78
pmol/l
0.55
549
4812
121
860
1.42
3.37
1.5
1.7
1.15
1.19
g/l
0.98
116
820
188
1437
1.33
3.35
1.5
1.5
—
—
—
0
0
615
5360
1.18
3.35
1.5
1.5
2.53
2.46
g/l
0.36
385
3460
1084
9871
1.15
3.30
4.4
3.4
—
1.14
—
0
6
103
715
1.45
3.27
1.6
1.7
—
—
—
0
0
852
7634
1.16
3.25
4.3
3.3
0.41
0.43
e6/l
0.12
663
5624
34
177
1.93
3.23
1.1
1.2
—
1.73
—
0
5
263
2115
1.26
3.20
4.6
3.8
1.22
1.22
mmol/l
0.32
231
1832
535
4632
1.18
3.14
1.9
1.8
1170.64
1172.83
nmol/l
0.02
417
3540
234
1860
1.28
3.14
2.7
2.4
18.20
20.49
au/ml
0.19
30
223
112
800
1.41
3.07
3.2
2.4
3.61
3.59
g/l
0.04
106
762
56
345
1.63
3.06
1.8
1.7
—
—
—
0
0
16
62
2.59
3.04
1.3
1.1
—
—
—
0
0
17
68
2.51
3.04
1.3
1.1
—
—
—
0
0
12
36
3.34
3.01
1.2
1.2
—
—
—
0
0
104
736
1.43
3.01
1.4
1.4
—
—
—
0
0
87
595
1.47
3.01
2.3
2.9
33.59
35.76
umol/l
0.39
79
537
25
120
2.09
2.98
25.0
25.5
95.00
113.65
ug/l
1.19
19
97
21
94
2.24
2.96
1.3
1.1
—
—
—
0
0
211
1672
1.28
2.92
1.9
1.9
1.45
1.40
g/l
0.09
194
1550
23
108
2.14
2.90
1.2
1.1
—
—
—
0
0
9
22
4.10
2.88
1.2
1.1
—
—
—
0
0
327
2729
1.22
2.86
5.5
3.5
2.08
1.87
mmol/l
0.46
292
2339
128
948
1.36
2.85
1.8
1.8
—
—
—
0
0
8
18
4.45
2.79
1.0
1.3
—
—
—
0
0
975
8901
1.13
2.77
4.3
3.4
78.36
78.50
e6/l
0.00
782
6832
278
2290
1.23
2.77
3.0
2.6
65.98
66.60
g/l
0.65
256
2113
104
749
1.40
2.75
1.6
2.2
11.61
11.33
mg/l
0.15
96
698
80
1142
0.69
2.71
1.1
1.1
0.56
0.66
ratio
2.59
13
128
49
302
1.63
2.71
2.7
2.5
75.00
37.61
iu/ml
—
5
34
64
421
1.53
2.69
1.4
1.4
—
—
—
0
0
606
5368
1.16
2.67
4.6
3.9
254.42
399.87
ng/l
1.19
487
4125
72
487
1.49
2.66
1.8
1.5
160.81
152.02
au/ml
0.25
21
138
1165
10775
1.13
2.66
4.5
3.8
1.58
0.06
estimate
0.48
320
2408
17
73
2.34
2.65
1.3
1.1
—
—
—
0
0
117
866
1.36
2.64
1.2
1.3
—
—
—
0
0
138
1048
1.33
2.64
2.0
2.0
—
—
—
0
0
367
3124
1.20
2.63
4.0
4.3
236.97
246.11
u/l
0.73
350
2962
148
1144
1.31
2.51
2.1
1.9
2.44
1.63
ug/l
0.49
132
1000
97
706
1.39
2.45
1.1
1.1
4.30
3.63
—
9
103
20
96
2.09
2.42
1.2
1.0
—
—
—
0
0
63
425
1.49
2.39
1.1
1.1
102.33
1525.86
iu/ml
0.49
15
87
15
64
2.35
2.38
1.1
1.1
—
—
—
0
0
117
884
1.34
2.35
3.1
3.3
48.72
54.79
mg/l
0.32
95
753
83
593
1.41
2.35
2.3
2.4
49.43
116.47
ug/min
2.00
51
366
16
71
2.26
2.34
1.4
1.0
—
—
—
0
0
45
283
1.60
2.34
1.4
1.8
—
—
—
0
0
117
886
1.33
2.32
3.1
3.3
33.45
74.64
mg/l
1.53
95
758
15
65
2.31
2.31
1.2
1.1
—
—
—
0
0
40
245
1.64
2.31
1.4
1.6
0.79
1.27
promille
1.47
34
193
278
2338
1.21
2.29
4.8
2.9
4.77
4.57
kpa
0.77
267
2268
30
170
1.77
2.28
1.5
2.8
599.96
579.34
e6/l
0.05
25
145
10
34
2.95
2.28
1.4
2.4
—
—
—
0
0
12
47
2.56
2.27
2.0
1.7
—
—
—
0
0
39
239
1.64
2.25
1.2
1.2
5.33
0.60
u/ml
1.35
25
129
61
415
1.48
2.24
2.8
3.8
1.04
1.50
%
0.99
54
376
27
149
1.82
2.24
1.3
1.2
—
—
—
0
0
87
633
1.38
2.23
1.3
1.2
2.86
3.80
u/ml
—
9
42
313
2670
1.19
2.22
3.4
2.6
34.04
58.37
u/l
0.75
272
2290
156
1237
1.27
2.22
1.9
1.8
1.48
1.54
g/l
0.30
136
1068
1086
10091
1.11
2.21
4.8
4.0
139.96
93.45
e6/l
0.35
824
7212
5
9
5.56
2.21
1.2
1.0
—
—
—
0
0
205
1680
1.23
2.19
3.5
3.6
4.45
4.49
pmol/l
0.29
193
1505
146
1150
1.28
2.19
1.8
1.9
3.91
6.90
iu/ml
1.67
35
288
8
24
3.34
2.18
1.0
1.3
—
—
—
0
0
110
835
1.33
2.17
4.1
2.9
1.71
1.52
mg/l
1.20
103
762
91
1218
0.74
2.15
1.1
1.2
1.47
1.51
g/l
0.92
91
1218
106
802
1.33
2.14
1.3
1.3
—
—
—
0
0
35
212
1.66
2.13
1.7
1.8
—
—
—
0
0
762
6957
1.12
2.11
5.1
4.2
89.64
89.32
%
0.14
746
6809
47
307
1.54
2.11
2.6
2.1
1.49
0.45
mmol/l
0.94
42
298
83
609
1.37
2.05
1.6
1.4
525.08
1487.70
e6/l
0.95
63
484
73
525
1.40
2.03
1.4
1.2
308.62
275.55
u/ml
0.35
50
327
103
783
1.33
2.03
1.4
1.3
6.58
10.70
u/ml
0.41
13
122
32
192
1.67
2.03
1.2
1.2
75.78
85.10
—
5
10
842
7752
1.12
2.01
3.9
3.3
0.82
0.07
estimate
0.45
308
2288
2519
25846
0.90
2.00
5.0
4.9
1.43
1.43
mmol/l
0.09
2366
24171
2535
25997
0.90
1.98
5.1
5.0
4.60
4.64
mmol/l
1.27
2388
24447
2407
24745
0.90
1.94
4.3
4.2
1.33
1.32
mmol/l
0.27
2241
22962
593
5361
1.13
1.94
3.0
2.9
2.45
2.45
mmol/l
0.09
528
4801
19
99
1.92
1.90
3.0
3.3
9.25
8.79
mg/l
0.13
13
82
273
2339
1.18
1.88
2.5
2.4
9.30
7.52
ug/l
0.40
232
2042
12
52
2.31
1.87
1.0
1.2
1.21
1.60
mmol/l
—
7
35
101
780
1.30
1.81
1.4
1.3
4.59
3.49
u/ml
—
9
69
23
130
1.77
1.81
1.4
2.6
102.36
126.38
umol/l
0.27
14
76
44
295
1.50
1.79
2.7
3.2
9.88
10.58
mmol/l
0.79
44
288
17
87
1.96
1.79
1.2
1.7
—
—
—
0
0
26
153
1.70
1.79
1.2
1.4
132.77
138.43
nmol/l
0.41
26
153
8
29
2.76
1.79
2.0
1.4
—
—
—
0
0
107
835
1.29
1.78
1.3
1.2
88.47
28.20
u/ml
—
7
41
102
791
1.30
1.78
3.1
3.2
2.82
4.06
ratio
0.41
58
460
29
177
1.64
1.76
1.8
2.0
—
—
—
0
0
76
566
1.35
1.75
1.3
1.2
—
92.05
—
0
10
80
601
1.34
1.75
1.6
1.4
23.54
38.00
e6/l
0.36
59
445
307
2676
1.16
1.72
4.3
4.2
81.00
18.33
ug/l
0.62
260
2180
30
186
1.62
1.72
1.0
1.1
4.63
9.47
iu/ml
—
7
62
72
534
1.36
1.71
1.4
1.4
—
—
—
0
0
2579
26366
0.90
1.69
5.7
5.5
2.70
2.74
mmol/l
1.14
2416
24690
153
1257
1.23
1.67
2.4
2.2
0.00
0.65
estimate
0.51
36
393
8
31
2.58
1.66
1.6
1.1
—
—
—
0
0
69
512
1.36
1.65
1.2
1.2
136.00
389.27
titre
—
5
41
27
165
1.64
1.64
1.6
2.0
—
—
—
0
0
11
49
2.25
1.63
1.0
1.4
—
—
—
0
0
178
1491
1.20
1.61
4.4
2.7
1.30
1.25
%
0.24
178
1481
88
680
1.30
1.60
1.6
1.6
8958.42
13474.05
e6/l
1.08
62
476
39
262
1.49
1.60
1.5
1.9
—
—
—
0
0
57
412
1.39
1.60
1.1
1.1
11.50
3.42
u/ml
0.82
25
172
17
91
1.87
1.60
2.8
2.9
0.60
0.62
mmol/l
0.47
17
91
15
77
1.95
1.59
1.0
1.2
99.67
90.12
%
—
6
43
161
1339
1.21
1.57
1.1
1.1
—
—
—
0
0
96
754
1.28
1.56
1.5
1.4
—
—
—
0
0
22
130
1.70
1.52
2.3
2.6
—
—
—
0
0
45
315
1.43
1.52
1.3
1.5
279.63
278.72
mosm/kgh2o
0.08
32
234
35
233
1.51
1.51
1.5
1.5
22.16
30.26
%
0.64
20
135
96
758
1.27
1.50
3.6
3.3
1.71
1.65
index
0.04
49
407
75
577
1.31
1.44
1.6
1.6
—
—
—
0
0
14
73
1.92
1.43
1.1
1.2
29.25
97.65
ug/l
—
8
31
33
221
1.50
1.41
1.2
1.1
39.65
40.66
mg/l
0.05
25
181
285
2516
1.15
1.39
2.1
1.9
—
—
—
0
0
81
635
1.28
1.37
1.3
1.2
41.66
45.60
u/ml
—
9
69
242
2116
1.15
1.35
3.4
3.0
202.29
218.97
ng/l
0.29
216
1909
15
82
1.83
1.35
1.7
1.4
10.48
8.50
ug/l
0.75
15
82
39
273
1.43
1.35
2.7
3.6
58.69
55.68
%
0.42
34
242
27
175
1.55
1.34
1.1
1.2
—
—
—
0
0
172
1466
1.18
1.33
4.4
2.6
0.59
0.62
%
0.67
172
1457
15
83
1.81
1.31
1.3
2.3
54060.00
23382.43
e6/l
—
8
51
557
5134
1.10
1.30
1.4
1.3
29.84
29.68
iu/ml
0.01
176
1583
30
201
1.50
1.29
1.1
1.1
—
—
—
0
0
5
18
2.78
1.28
1.2
1.0
—
—
—
0
0
2813
28544
0.91
1.27
30.4
24.0
253.88
250.50
e9/l
1.99
2767
28022
964
9115
1.08
1.26
4.2
3.5
7.54
7.82
mmol/l
1.18
838
7780
2815
28561
0.91
1.26
30.6
24.2
134.79
135.91
g/l
3.51
2791
28261
58
440
1.32
1.26
5.2
5.8
364.43
357.55
umol/l
0.16
52
384
2456
25066
0.92
1.26
5.1
4.9
6.00
5.95
mmol/l
1.05
2288
23161
2815
28557
0.91
1.24
31.1
24.5
40.41
40.83
%
1.04
2789
28234
2816
28566
0.91
1.24
30.5
24.1
6.90
6.77
e9/l
2.15
2765
27962
2815
28556
0.91
1.24
30.4
24.0
4.48
4.51
e12/l
3.03
2758
27956
2815
28552
0.91
1.22
30.3
24.0
91.17
91.06
fl
0.69
2792
28242
10
49
2.04
1.22
1.1
1.3
—
7410.00
—
0
5
77
611
1.27
1.21
1.6
1.6
—
—
—
0
0
14
78
1.80
1.21
1.0
1.5
108.50
91.42
%
—
6
45
63
488
1.30
1.19
1.4
1.7
—
—
—
0
0
298
2669
1.13
1.19
2.6
2.4
13.31
13.53
nmol/l
0.20
270
2460
32
222
1.45
1.18
1.3
1.2
—
33.25
—
0
8
28
189
1.49
1.18
2.1
2.3
830.76
638.15
ml
1.04
21
124
62
480
1.30
1.18
1.7
1.8
—
—
—
0
0
24
157
1.53
1.17
1.3
1.4
—
—
—
0
0
21
133
1.58
1.17
1.7
1.3
86.88
69.73
%
—
8
15
11
57
1.93
1.17
1.5
1.2
211.17
279.26
pmol/l
—
6
42
51
385
1.33
1.16
1.1
1.1
3.10
3.26
—
6
67
245
2174
1.14
1.14
3.0
2.7
68.47
68.70
ml/min/173m2
0.03
107
921
24
158
1.52
1.14
1.3
1.3
—
—
—
0
0
41
301
1.37
1.12
1.3
1.2
—
—
—
0
0
41
301
1.37
1.12
1.5
1.6
59.85
59.98
%
0.01
20
186
22
143
1.54
1.11
1.2
1.1
1875.78
1469.35
miu/ml
1.12
22
143
100
827
1.22
1.11
1.7
1.4
278.36
286.96
ug/g
0.16
59
481
148
1270
1.17
1.10
2.1
1.8
0.28
0.31
mg/l
0.22
75
630
357
3249
1.11
1.10
2.9
2.7
7.62
8.13
umol/l
0.27
318
2858
56
433
1.30
1.10
1.1
1.1
3.37
2.31
u/ml
0.30
24
206
912
8657
1.07
1.07
5.0
4.1
9.65
7.86
mg/mmol
0.56
613
5517
7
33
2.12
1.05
1.1
1.2
—
—
—
0
0
58
455
1.28
1.03
1.1
1.1
6.19
16.50
au/ml
2.36
12
126
47
359
1.31
1.02
1.7
1.6
—
—
—
0
0
123
1048
1.18
1.01
1.6
1.7
17.91
15.39
u/ml
0.20
21
262
43
563
0.76
1.01
6.0
3.2
8.46
7.53
mmol/l
1.19
43
544
1937
18873
1.06
1.00
3.7
3.3
49.20
48.78
u/l
0.06
1840
17882
781
7394
1.07
0.99
2.9
2.6
340.13
346.32
umol/l
0.97
685
6558
23
157
1.47
0.96
1.7
1.6
7.13
5.92
u/l
0.16
18
127
122
1045
1.17
0.96
1.6
1.8
5.75
4.72
mg/l
0.18
95
785
49
381
1.29
0.95
1.1
1.0
0.19
0.19
u/ml
0.03
19
116
9
51
1.77
0.94
1.4
1.1
85.89
95.88
%
—
9
51
41
312
1.32
0.93
2.6
2.3
22.00
21.23
mg/l
0.05
19
122
71
583
1.22
0.89
5.8
2.1
1.12
0.90
nmol/l
0.74
59
502
6
30
2.00
0.87
3.7
2.5
0.17
0.93
u/field
—
6
30
38
290
1.31
0.86
1.7
1.8
46.84
21.73
ug/l
0.44
38
283
404
3752
1.09
0.85
1.6
1.5
—
—
—
0
0
1274
12307
1.06
0.84
3.1
2.7
—
—
estimate
—
0
0
6
31
1.94
0.84
1.8
1.5
—
—
—
0
0
15
96
1.57
0.84
2.3
1.7
40.86
40.03
g/l
0.18
15
96
76
908
0.83
0.84
1.5
1.5
—
—
—
0
0
502
4709
1.08
0.83
1.4
1.3
11.17
10.84
u/ml
0.04
196
1912
6
32
1.88
0.81
9.0
10.0
5.00
5.85
mmol/l
—
6
32
14
89
1.58
0.81
1.6
1.6
—
—
—
0
0
48
382
1.26
0.81
1.2
1.1
—
11.21
—
0
15
2653
26175
1.07
0.80
21.3
16.1
24.10
24.50
mg/l
0.25
2298
21727
19
131
1.45
0.78
1.2
1.5
—
—
—
0
0
19
131
1.45
0.78
1.2
1.5
—
—
—
0
0
43
340
1.27
0.77
1.2
1.3
—
—
—
0
0
52
422
1.24
0.75
1.3
1.3
—
—
—
0
0
13
83
1.57
0.75
1.1
1.2
—
—
—
0
0
9
55
1.64
0.73
1.0
1.1
—
—
—
0
0
18
125
1.44
0.72
1.1
1.1
—
38.77
—
0
13
7
39
1.80
0.72
1.1
1.2
—
—
—
0
0
503
4747
1.07
0.72
3.9
3.0
1.08
1.24
e6/l
0.34
278
2512
97
840
1.16
0.72
1.3
1.4
11.71
9.15
u/l
0.83
82
673
16
109
1.47
0.70
2.0
2.2
145.63
140.37
nmol/l
0.10
16
94
69
582
1.19
0.70
1.2
1.1
0.70
1.80
u/ml
1.68
35
294
9
58
1.55
0.69
1.7
2.3
16.89
16.18
umol/l
—
9
58
23
169
1.36
0.69
1.7
1.5
—
—
—
0
0
21
152
1.38
0.69
1.8
1.7
81.35
107.15
ng/l
1.81
21
152
301
2792
1.09
0.68
2.1
2.0
—
—
—
0
0
2229
21924
1.05
0.68
24.2
19.4
13.74
13.63
%
3.42
2205
21622
179
1620
1.11
0.68
1.3
1.4
23.71
26.28
iu/l
0.56
155
1387
25
187
1.34
0.68
1.7
1.4
—
—
—
0
0
76
649
1.18
0.68
1.2
1.2
—
—
—
0
0
30
231
1.30
0.67
1.2
1.5
—
—
—
0
0
2733
27618
0.94
0.67
13.8
11.7
26.48
27.20
u/l
1.38
2666
26913
138
1233
1.12
0.66
1.4
1.4
—
—
—
0
0
7
44
1.59
0.65
2.3
2.3
—
—
—
0
0
10
62
1.61
0.65
1.0
1.2
—
—
—
0
0
17
120
1.42
0.64
1.0
1.1
106.94
97.57
%
0.65
17
97
48
580
0.83
0.64
4.1
3.5
16.71
26.92
mg/l
2.70
28
406
306
3281
0.93
0.64
2.0
2.0
3.67
3.61
ratio
0.36
233
2545
42
341
1.23
0.63
1.3
1.3
5.62
56.26
u/ml
—
5
17
655
6265
1.06
0.62
4.7
4.0
1.02
1.26
kg/l
0.50
478
4141
52
433
1.20
0.62
1.2
1.2
3.71
5.25
u/ml
0.54
24
203
61
516
1.19
0.62
1.9
1.3
23.73
33.80
u/l
0.69
54
444
22
164
1.34
0.62
1.8
1.5
—
—
—
0
0
324
3030
1.08
0.62
4.6
4.7
32.52
31.72
%
0.56
223
2054
84
730
1.15
0.62
1.2
1.2
—
—
—
0
0
46
379
1.22
0.61
1.1
1.4
0.65
5.25
nmol/l
0.49
46
366
30
235
1.28
0.61
1.3
1.7
—
—
—
0
0
30
235
1.28
0.61
1.3
1.7
—
—
—
0
0
30
235
1.28
0.61
1.3
1.7
—
—
—
0
0
190
1739
1.10
0.60
5.0
3.1
125.58
129.96
g/l
1.94
190
1690
99
873
1.14
0.60
2.3
2.0
209.13
210.83
pmol/l
0.05
99
831
83
723
1.15
0.60
2.0
2.0
5.50
11.61
iu/l
0.37
31
311
33
411
0.80
0.59
1.1
1.1
2.38
2.36
eliau/ml
0.01
13
194
84
733
1.15
0.59
1.2
1.1
—
—
—
0
0
13
89
1.46
0.58
5.0
3.1
4.49
4.81
kpa
0.80
13
89
13
89
1.46
0.58
5.0
3.1
10.36
10.23
kpa
0.05
13
89
121
1087
1.12
0.56
2.9
2.2
3.60
3.76
g/l
0.73
113
995
17
124
1.37
0.55
1.2
1.1
—
—
—
0
0
62
532
1.17
0.55
3.3
3.6
12030.99
808.52
u/ml
0.58
56
499
121
1088
1.12
0.55
2.9
2.2
7.75
7.38
g/l
1.29
113
996
121
1088
1.12
0.55
2.9
2.2
4.12
4.22
g/l
0.65
113
996
2452
24805
0.96
0.54
6.9
6.1
39.74
39.24
mmol/mol
1.87
2309
23361
22
169
1.30
0.53
1.5
1.2
0.60
0.58
ratio
—
10
94
2767
27907
0.95
0.53
25.7
20.3
78.34
78.92
umol/l
0.35
2747
27580
113
1016
1.12
0.52
2.8
2.2
2.95
2.95
g/l
0.01
104
924
381
3609
1.06
0.52
1.9
1.9
1.51
1.47
%
0.49
331
3201
9
63
1.43
0.52
1.1
1.2
—
—
—
0
0
73
831
0.88
0.51
2.4
2.2
4838.67
5358.26
u/l
0.04
22
299
33
269
1.23
0.51
4.0
2.6
—
—
—
0
0
31
252
1.23
0.49
3.9
3.4
13.90
12.67
index
0.33
21
144
7
45
1.56
0.49
2.3
2.3
—
—
—
0
0
14
189
0.74
0.48
2.0
1.5
93.79
80.49
umol/l
1.52
14
189
37
441
0.84
0.47
1.5
1.4
59.39
59.31
ug/l
0.00
30
329
53
457
1.16
0.47
2.1
2.0
4.33
5.07
mmol/24h
1.29
46
405
38
318
1.20
0.47
1.7
1.5
—
—
—
0
0
228
2434
0.93
0.46
1.7
1.7
3.53
3.53
mmol/l
0.00
160
1688
457
4373
1.05
0.46
4.0
3.1
2.70
2.30
e6/l
0.35
229
2126
51
440
1.16
0.45
1.1
1.1
—
—
—
0
0
30
246
1.22
0.45
1.2
1.1
—
—
—
0
0
35
292
1.20
0.45
1.2
1.3
5.96
6.40
mmol/l
0.40
29
276
27
219
1.23
0.45
1.3
1.2
101.67
108.19
pmol/l
0.43
27
219
25
201
1.25
0.45
16.2
20.9
1370.60
1437.35
nmol/l
0.19
25
196
22
174
1.27
0.44
1.3
1.9
—
—
—
0
0
56
488
1.15
0.44
1.2
1.1
0.91
1.38
u/ml
0.48
24
233
16
121
1.32
0.44
2.3
2.5
15.69
87.32
ug/l
0.55
16
106
25
202
1.24
0.43
1.7
1.6
—
—
—
0
0
20
157
1.28
0.43
1.5
1.5
1.58
1.28
nmol/l
0.63
15
115
5
31
1.61
0.43
1.2
1.0
—
—
—
0
0
103
936
1.10
0.42
1.6
1.8
—
—
—
0
0
53
462
1.15
0.42
1.3
1.4
0.27
0.43
nmol/l
1.96
41
355
2533
25099
1.04
0.41
19.4
15.3
82.81
81.65
ml/min/173m2
2.07
2361
23321
29
240
1.21
0.41
1.3
1.4
162.20
197.07
pmol/l
0.38
29
240
37
314
1.18
0.41
1.7
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
1.3
—
20.74
—
0
7
21
168
1.25
0.40
1.5
1.4
—
370.77
—
0
13
0
19
0.00
0.39
0.0
5.9
—
—
—
0
0
40
344
1.16
0.38
1.3
1.4
319.87
335.17
pmol/l
0.10
31
296
16
124
1.29
0.38
2.8
1.8
2.30
2.39
u/field
—
10
91
102
934
1.09
0.37
2.9
2.4
0.82
1.11
g/l
0.28
91
808
37
317
1.17
0.37
1.7
1.5
—
—
—
0
0
23
188
1.22
0.37
1.3
1.2
—
—
—
0
0
23
188
1.22
0.37
1.3
1.2
—
—
—
0
0
23
279
0.82
0.37
1.8
1.5
—
—
—
0
0
107
983
1.09
0.37
3.3
3.5
86.40
4323.65
u/ml
0.90
92
851
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
20
161
1.24
0.37
1.0
1.1
1.06
1.11
u/l
—
10
78
18
144
1.25
0.35
1.6
3.5
—
—
—
0
0
26
218
1.19
0.34
1.6
2.0
12.00
9.88
umol/l
0.22
18
153
98
902
1.09
0.34
1.5
1.3
—
—
—
0
0
24
200
1.20
0.33
1.2
1.1
—
—
—
0
0
16
127
1.26
0.33
1.0
1.1
—
—
—
0
0
35
305
1.15
0.30
1.7
1.5
—
—
—
0
0
103
956
1.08
0.30
3.0
2.2
10.25
10.42
g/l
0.14
94
859
30
259
1.16
0.29
1.3
1.3
—
—
—
0
0
46
514
0.89
0.29
1.7
1.4
—
—
—
0
0
37
419
0.88
0.29
1.4
1.4
0.99
0.96
ratio
0.22
24
236
37
419
0.88
0.29
1.4
1.4
1.06
1.18
ratio
0.39
24
236
37
419
0.88
0.29
1.4
1.4
1.14
1.17
ratio
0.06
24
236
37
419
0.88
0.29
1.4
1.4
—
—
—
0
0
63
574
1.10
0.28
3.9
3.3
0.90
0.84
nmol/l
0.27
51
469
109
1018
1.07
0.28
1.4
1.6
265.07
291.25
mu/l
0.52
98
941
8
63
1.27
0.27
1.0
1.0
24.32
44.03
iu/ml
—
8
63
31
354
0.87
0.27
1.4
1.4
—
—
—
0
0
21
247
0.85
0.27
1.0
1.0
—
—
—
0
0
37
328
1.13
0.26
1.1
1.4
0.20
0.24
nmol/l
0.31
29
257
25
215
1.16
0.26
1.2
1.1
—
—
—
0
0
16
132
1.21
0.25
1.5
2.1
—
—
—
0
0
16
132
1.21
0.25
1.5
2.1
—
—
—
0
0
16
132
1.21
0.25
1.5
2.1
—
—
—
0
0
16
132
1.21
0.25
1.5
2.1
—
—
—
0
0
15
123
1.22
0.25
1.1
1.4
114.00
175.49
mmol/24h
2.94
15
123
79
733
1.08
0.25
3.1
2.3
0.00
0.00
g/l
-0.00
74
686
24
207
1.16
0.25
1.2
1.1
—
—
—
0
0
24
207
1.16
0.25
1.0
1.1
19.81
17.18
u/ml
—
7
88
24
207
1.16
0.25
1.2
1.1
—
—
—
0
0
37
330
1.12
0.25
1.5
1.4
3998.41
1659.28
e6/l
0.56
29
224
72
776
0.93
0.24
1.6
1.5
—
—
—
0
0
672
6585
1.03
0.23
2.9
2.4
—
—
—
0
0
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
86
805
1.07
0.23
2.9
2.2
0.02
0.02
g/l
0.16
78
723
34
304
1.12
0.22
1.7
1.5
—
—
—
0
0
34
304
1.12
0.22
1.7
1.5
—
—
—
0
0
493
4813
1.03
0.22
1.6
1.5
—
—
—
0
0
5
40
1.25
0.22
2.2
1.7
173.60
29.72
pmol/l
—
5
35
23
200
1.15
0.22
1.2
1.1
—
—
—
0
0
5
41
1.22
0.22
3.6
2.1
—
—
—
0
0
17
144
1.18
0.22
1.2
1.2
—
—
—
0
0
157
1501
1.05
0.21
2.2
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
93.80
—
0
5
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
81.42
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
5
43
1.16
0.21
1.2
1.5
—
—
—
0
0
6
48
1.25
0.20
2.5
2.8
—
—
—
0
0
20
229
0.87
0.20
1.4
1.5
58.98
59.11
ug/l
0.00
20
229
20
174
1.15
0.19
1.9
3.0
42.87
40.86
%
0.22
15
92
25
222
1.13
0.19
2.4
2.1
3.42
1.86
u/field
0.48
12
121
83
784
1.06
0.18
3.0
2.3
0.01
0.00
g/l
0.49
74
687
26
290
0.90
0.18
2.0
1.7
—
—
—
0
0
12
100
1.20
0.18
1.6
2.3
—
—
—
0
0
12
100
1.20
0.18
1.6
2.3
—
—
—
0
0
12
100
1.20
0.18
2.1
2.3
—
—
—
0
0
10
121
0.83
0.18
1.4
1.4
8.90
7.95
mmol/l
—
10
116
68
723
0.94
0.17
1.5
1.5
1048.11
1094.16
mu/l
0.15
51
531
2402
24137
0.98
0.17
5.6
5.2
1.88
1.88
mu/l
0.00
2256
22475
29
319
0.91
0.16
3.0
2.3
4.15
4.06
mmol/l
0.74
29
313
29
319
0.91
0.16
3.0
2.3
105.66
105.77
mmol/l
0.05
29
313
719
7295
0.98
0.16
4.0
4.1
22.00
21.58
%
0.24
305
3248
14
120
1.17
0.16
3.2
3.8
1.21
1.15
%
0.07
14
120
24
217
1.11
0.14
1.1
1.2
530.00
167.35
titre
—
5
34
12
139
0.86
0.14
1.3
1.3
—
—
—
0
0
126
1215
1.04
0.14
2.1
1.9
—
—
—
0
0
47
441
1.07
0.13
1.3
1.2
6.11
3.80
u/ml
0.20
19
153
2045
20345
1.01
0.13
4.6
4.3
14.89
14.71
pmol/l
2.53
1920
18825
56
529
1.06
0.13
1.1
1.1
3.38
4.27
u/ml
0.27
24
269
1088
10979
0.99
0.13
1.9
1.9
1.42
1.41
mmol/l
0.10
923
9431
29
313
0.93
0.12
3.0
2.3
1.21
1.19
mmol/l
0.72
29
307
126
1299
0.97
0.11
4.2
3.4
1.02
1.02
ratio
0.29
117
1174
13
146
0.89
0.10
1.1
1.1
—
—
—
0
0
304
2990
1.02
0.10
7.7
7.2
—
—
—
0
0
53
507
1.05
0.09
1.1
1.1
0.62
1.13
u/ml
0.63
20
206
229
2249
1.02
0.09
2.9
2.4
0.40
0.46
e6/l
0.23
219
2141
34
321
1.06
0.09
1.7
1.6
291.15
336.75
mu/l
0.68
26
258
6
55
1.09
0.08
1.2
1.4
—
0.82
—
0
5
23
214
1.08
0.08
2.0
1.6
—
—
—
0
0
23
246
0.93
0.08
1.3
1.5
1.68
3.47
ug/l
1.38
18
211
11
98
1.12
0.07
1.5
1.4
—
—
—
0
0
920
9142
1.01
0.07
4.7
4.9
2.24
3.06
ug/l
0.81
840
8300
22
235
0.94
0.07
7.3
5.4
326.36
81.35
u/ml
—
7
74
22
206
1.07
0.07
2.2
2.3
23.76
32.18
mg/l
0.67
17
145
26
246
1.06
0.06
1.0
1.1
288.42
281.38
mg/l
0.21
26
226
26
246
1.06
0.06
1.4
1.3
4561.76
110226.09
e6/l
1.65
21
157
12
109
1.10
0.06
1.1
1.2
—
—
—
0
0
13
141
0.92
0.05
2.0
1.8
3.04
3.52
nmol/l
—
8
112
2660
26561
1.01
0.05
23.9
18.6
139.46
139.63
mmol/l
2.91
2614
26053
71
727
0.98
0.05
1.1
1.1
4.16
4.06
eliau/ml
—
7
97
12
110
1.09
0.05
1.4
1.4
—
—
—
0
0
12
110
1.09
0.05
1.4
1.4
—
—
—
0
0
25
238
1.05
0.05
1.2
1.3
—
—
—
0
0
44
426
1.03
0.05
1.4
1.4
25.26
25.92
u/l
0.05
36
347
181
1830
0.99
0.04
1.2
1.2
138.65
146.94
u/ml
0.10
66
691
547
5496
0.99
0.03
3.0
3.0
0.72
0.75
ug/l
0.38
338
3313
14
146
0.96
0.00
1.0
1.2
9.79
9.02
mm/h
0.10
14
146
82
814
1.01
0.00
1.2
1.3
214.38
202.38
miu/ml
0.12
34
367
2664
26634
1.00
0.00
24.2
18.7
3.98
3.98
mmol/l
0.12
2611
26080
10
102
0.98
0.00
1.5
1.2
—
—
—
0
0
17
168
1.01
0.00
2.2
2.1
7.46
8.27
mmol/l
0.42
17
168
35
355
0.99
0.00
1.1
1.1
—
—
—
0
0
15
151
0.99
0.00
2.4
8.4
—
52.10
u/ml
—
0
41
28
283
0.99
0.00
1.7
1.4
22829.23
46118.50
e6/l
0.46
22
159
15
153
0.98
0.00
10.8
7.3
130.75
122.51
ug/l
—
10
105
0
8
0.00
-0.00
0.0
1.0
—
1141.63
—
0
8
0
6
0.00
-0.00
0.0
12.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.01
—
0
5
5
54
0.93
-0.00
1.0
1.1
1.20
1.19
mmol/l
—
5
54
6
69
0.87
-0.00
1.2
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
338.67
—
0
6
0
7
0.00
-0.00
0.0
13.9
—
1660.57
—
0
7
5
57
0.88
-0.00
10.4
6.7
6.03
6.02
kpa
—
5
50
8
80
1.00
-0.00
1.6
1.1
—
—
—
0
0
5
50
1.00
-0.00
10.4
6.8
6.58
5.37
kpa
—
5
50
7
77
0.91
-0.00
1.0
1.1
—
—
—
0
0
6
64
0.94
-0.00
1.3
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
11.8
—
—
—
0
0
5
49
1.02
-0.00
1.8
2.4
8.80
2.43
%
—
5
49
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
-0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES | 1.847 [1.66, 2.06] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.14 |
During the follow-up period (1.1.1998 — 31.12.2019), 1440 out of 2917 females with AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES | 2.058 [1.82, 2.33] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 2077 out of 3401 males with AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES died.
Mortality risk
Mortality risk for people of age
years, who have AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.149% | 0.359% |
| 5 | 0.929% | 2.127% |
| 10 | 2.57% | 5.136% |
| 15 | 4.969% | 10.246% |
| 20 | 8.474% | 17.367% |
Relationships between endpoints
↥Index endpoint: AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES – Sequelae of infectious and parasitic diseases
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data